Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-27

Clinical Trial Update: The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection [NA]

View source ↗

Summary

A clinical trial assessed the effect of raltegravir on HIV decay during primary and chronic HIV infection; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raltegravir (raltegravir)

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infection | NA | Status: COMPLETED | Results posted: 2013-05-27